Navigation Links
Medical Device Study Examines Use of Emerging Markets and Outsourcing for Clinical Activities
Date:2/17/2012

CHAPEL HILL, N.C., Feb. 17, 2012 /PRNewswire/ -- Medical device organizations are experiencing two dynamics in mature markets like North America and Europe: Clinical costs are continuing to rise and sales are either growing negligibly or not at all.

In emerging markets, meanwhile, device organizations are experiencing lower clinical costs and rapidly rising sales. While mature markets still represent a lion's share of most device companies' sales, emerging markets represent significant cost savings and important future sales. And large countries like China and India are now requiring local clinical trials to win regulatory approvals to market products in those countries.

What this all adds up to is more medical device organizations are evaluating an expansion of their clinical programs into emerging markets to cut costs and boost sales.

A study from research and consulting firm Best Practices, LLC, Clinical Affairs Excellence: Benchmarking Clinical Trial Strategies to Ensure Medical Device Success in a Global Marketplace, delivers hard-to-find benchmarks on medical device clinical programs' presence in emerging markets, activities outsourced, staffing and budgets.

This study analyzes factors associated with outsourcing clinical trial activities – including cost, staffing and quality – to help clinical leaders evaluate their organization's approach to outsourcing relative to peers. Through the qualitative (four executive interviews were done as part of this study) and quantitative data in this study, clinical leaders can formulate a strategic approach for engaging emerging regions in clinical affairs activities.

Critical outsourcing questions addressed in this survey include:

  • What are the regions where medical device companies are conducting clinical trials and the percent of patients recruited annually from these regions?
  • Which clinical trial activities are best suited for outsourcing?
  • What is the appropriate staffing mix (in-house and outsourced) for clinical trials?

This report will inform Clinical Affairs leaders on these questions and others regarding staffing, outsourcing and managing clinical trials outside of the U.S.

Research participants included 13 executives and managers from 11 medical device companies across a wide variety of therapeutic areas and product classes.

To access the full report or to download a complimentary summary containing insights found in this report, click on the following link: http://www3.best-in-class.com/rr1148.htm.

ABOUT BEST PRACTICES, LLC
Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations. Best Practices, LLC believes in the profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. 2WIN! ® Global Keynotes at Upcoming Medical Device Conference:
2. Millstone Medical Outsourcing Opens Sales Offices in CA, IN
3. Medical Design & Manufacturing Conference to be Launched in Texas in March 2012
4. Delcath Announces Agreement With University Medical Center Schleswig-Holstein for Use of Its Hepatic CHEMOSAT Delivery System
5. Varian Medical Systems to Equip New Proton Treatment Center in Russia
6. Medical Alarm Concepts Investor Update -- News on Current Initiatives
7. China Laboratory and Medical Sterilization Equipment and Apparatus Manufacturing Industry, 2012
8. To Take a Glance Cutting Edge Medicine Equipment! The 28th International Medical & Hospital Equipment Show
9. China Sky One Medical Reiterates CEO Sick Leave and Announces Significant Middle Management Resignations
10. Consumers Union to Testify for Stronger Medical Device Safety Oversight at House Hearing Today
11. Nationally Recognized Glenveigh Medical Announces Orphan Drug Designation for Treatment for Severe Preeclampsia and Eclampsia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)...  AbbVie (NYSE: ABBV), a global biopharmaceutical company, ... hepatitis C virus (HCV) infected patients with genotype ... cirrhosis (Child-Pugh A) achieved sustained virologic response at ... investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high ... weeks of G/P treatment without ribavirin. Patients with ...
(Date:4/20/2017)... 2017 Research and Markets has announced ... Services Market Analysis By Service (Manufacturing, Research), By Country, (Brazil, ... 2025" report to their offering. ... The Latin American pharmaceutical contract manufacturing services ... Low drug registration cost in Latin American countries ...
(Date:4/19/2017)... VIEW, Calif. , April 19, 2017  IRIDEX ... it will release financial results for the first quarter ... 3, 2017.  The Company,s management team will host a ... 5:30 p.m. ET. Investors interested in listening ... (844) 707-0665 for domestic callers or (703) 326-3030 for ...
Breaking Medicine Technology:
(Date:4/26/2017)... ... April 26, 2017 , ... Elisabete Miranda, ... been honored by Enterprising Women magazine as one of its 2017 Enterprising Women ... business owners. Winners have demonstrated that they have fast-growth businesses, mentor or actively ...
(Date:4/26/2017)... ... April 26, 2017 , ... RawTrition now brings you BioEnergy which is ... from SUPERFOODS! , RawTrition is taking nutrients to the next level! ... body recognizes its raw form (unlike the synthetically made options that are on the ...
(Date:4/26/2017)... , ... April 26, 2017 , ... ... performance, is proud to announce that it has received 510(k) clearance from the ... MyoCycle Home and the MyoCycle Pro. , Both devices are stationary cycling systems ...
(Date:4/25/2017)... , ... April 25, 2017 ... ... in Newport Beach, California, committed to raising awareness for Duchenne muscular dystrophy, ... from its randomized CAP-1002 (cardiosphere-derived cells) Phase I/II HOPE clinical trial in ...
(Date:4/25/2017)... ... ... The doctors at Wall Centre Dental are now expanding their practice by accepting ... receive dental care. The doctors offer three treatment options to put victims of ... at their dental office in Vancouver. Wall Centre Dental is currently welcoming even patients ...
Breaking Medicine News(10 mins):